Cercador de Publicacions

La producció científica dels nostres investigadors i investigadores és molt elevada. L'any 2022 es van publicar 1.629 articles a revistes científiques amb un factor d'impacte global que va superar els 15.000 punts.

Drotrecogin Alfa (Activated) in Adults with Septic Shock.

PMID: 22616830
Revista: NEW ENGLAND JOURNAL OF MEDICINE
Any: 2012
Referència: N Engl J Med. 2012 May 31;366(22):2055-64. doi: 10.1056/NEJMoa1202290. Epub 2012 May 22.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1056/NEJMoa1202290

Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.

PMID: 22610782
Revista: HEPATOLOGY
Any: 2012
Referència: Hepatology. 2012 Nov;56(5):1849-60. doi: 10.1002/hep.25845. Epub 2012 Oct 14.
Factor d'impacte: 11.665
Tipus de publicació: Article en revista internacional
Autors: , , , , , , , , , et al.
DOI: 10.1002/hep.25845

Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.

PMID: 22610782
Revista: HEPATOLOGY
Any: 2012
Referència: Hepatology. 2012 Nov;56(5):1849-60. doi: 10.1002/hep.25845. Epub 2012 Oct 14.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1002/hep.25845

Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer.

PMID: 22189054
Revista: Molecular Oncology
Any: 2012
Referència: Mol Oncol. 2012 Feb;6(1):15-26. Epub 2011 Dec 6.
Factor d'impacte: 5.082
Tipus de publicació: Revisió en revista internacional
Autors: , , , et al.
DOI: 10.1016/j.molonc.2011.11.009

Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer.

PMID: 22189054
Revista: Molecular Oncology
Any: 2012
Referència: Mol Oncol. 2012 Feb;6(1):15-26. Epub 2011 Dec 6.
Factor d'impacte:
Tipus de publicació: Revisió en revista internacional
Autors: ; ; ; et al.
DOI: 10.1016/j.molonc.2011.11.009

Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen.

PMID: 22378681
Revista: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Any: 2012
Referència: J Antimicrob Chemother. 2012 Jun;67(6):1453-8. doi: 10.1093/jac/dks057. Epub 2012 Feb 29.
Factor d'impacte: 5.068
Tipus de publicació: Article en revista internacional
Autors: , , , , , , , , , et al.
DOI: 10.1093/jac/dks057

Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen.

PMID: 22378681
Revista: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Any: 2012
Referència: J Antimicrob Chemother. 2012 Jun;67(6):1453-8. doi: 10.1093/jac/dks057. Epub 2012 Feb 29.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1093/jac/dks057

E. coli O104:H4 outbreak and haemolytic-uraemic syndrome.

PMID: 22244215
Revista: Medicina Intensiva
Any: 2012
Referència: Med Intensiva. 2012 Nov;36(8):576-83. doi: 10.1016/j.medin.2011.11.022. Epub 2012 Jan 13.
Factor d'impacte: 1.072
Tipus de publicació: Revisió en revista nacional
Autors: , , et al.
DOI: 10.1016/j.medin.2011.11.022

E. coli O104:H4 outbreak and haemolytic-uraemic syndrome.

PMID: 22244215
Revista: Medicina Intensiva
Any: 2012
Referència: Med Intensiva. 2012 Nov;36(8):576-83. doi: 10.1016/j.medin.2011.11.022. Epub 2012 Jan 13.
Factor d'impacte:
Tipus de publicació: Revisió en revista nacional
Autors: ; ; et al.
DOI: 10.1016/j.medin.2011.11.022

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

PMID: 23110958
Revista: Clinical & Translational Oncology
Any: 2012
Referència: Clin Transl Allergy. 2012 Oct 30;2(1):20. doi: 10.1186/2045-7022-2-20.
Factor d'impacte: 1.327
Tipus de publicació: Article en revista internacional
Autors: Demoly, Pascal, Gerth van Wijk, Roy, Bousquet, Jean, Sheikh, Aziz, Frew, Anthony, Scadding, Glenis, Bachert, Claus, Malling, Hans J, Valenta, Rudolph, Bilo, Beatrice et al.
DOI: 10.1186/2045-7022-2-20

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

PMID: 23110958
Revista: Clinical & Translational Oncology
Any: 2012
Referència: Clin Transl Allergy. 2012 Oct 30;2(1):20. doi: 10.1186/2045-7022-2-20.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Akdis, Cezmi; Alvarez-Cuesta, Emilio; Bachert, Claus; Bilo, Beatrice; Bohle, Barbara; Bousquet, Jean; Bufe, Albrecht; Calderon, Moises A; Canonica, Walter G; Cardona, Victoria et al.
DOI: 10.1186/2045-7022-2-20

Early Subclinical Rejection as a Risk Factor for Late Chronic Humoral Rejection.

PMID: 22094957
Revista: TRANSPLANTATION
Any: 2012
Referència: Transplantation. 2012 Jan 15;93(1):41-6.
Factor d'impacte: 4.003
Tipus de publicació: Article en revista internacional
Autors: , , , , , , , et al.
DOI: 10.1097/TP.0b013e31823bb647

Early Subclinical Rejection as a Risk Factor for Late Chronic Humoral Rejection.

PMID: 22094957
Revista: TRANSPLANTATION
Any: 2012
Referència: Transplantation. 2012 Jan 15;93(1):41-6.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: ; ; ; ; ; ; ; et al.
DOI: 10.1097/TP.0b013e31823bb647

Early treatment with eculizumab in atypical haemolytic uraemic syndrome.

PMID: 26069743
Revista: Clinical kidney journal
Any: 2012
Referència: Clin Kidney J. 2012 Feb;5(1):31-3. doi: 10.1093/ndtplus/sfr157. Epub 2012 Jan 31.
Factor d'impacte: 0
Tipus de publicació: Carta o abstract
Autors: Garjau, Maria, Azancot, Maria, Ramos, Rosa, Sanchez-Corral, Pilar, Montero, Maria Angeles, Seron, Daniel et al.
DOI: 10.1093/ndtplus/sfr157

Early treatment with eculizumab in atypical haemolytic uraemic syndrome.

PMID: 26069743
Revista: Clinical kidney journal
Any: 2012
Referència: Clin Kidney J. 2012 Feb;5(1):31-3. doi: 10.1093/ndtplus/sfr157. Epub 2012 Jan 31.
Factor d'impacte:
Tipus de publicació: Carta o abstract
Autors: Azancot, Maria; Azancot, Maria; Garjau, Maria; Montero, Maria Angeles; Ramos, Rosa; Sanchez-Corral, Pilar; Seron, Daniel et al.
DOI: 10.1093/ndtplus/sfr157

Early warning of EUSIG-defined hypotensive events using a Bayesian Artificial Neural Network.

PMID: 22327662
Revista: CT F-CIENC TECN FUT
Any: 2012
Referència: Acta Neurochir Suppl. 2012;114:39-44. doi: 10.1007/978-3-7091-0956-4_8.
Factor d'impacte: 1.52
Tipus de publicació: Article en revista internacional
Autors: Kiening, K, Mattern, J, Nilsson, P, Ragauskas, A, Sahuquillo, Juan, Sinnott, R, Stell, A, Gregson, B, Enblad, P, Chambers, I et al.
DOI: 10.1007/978-3-7091-0956-4_8

Early warning of EUSIG-defined hypotensive events using a Bayesian Artificial Neural Network.

PMID: 22327662
Revista: ACTA NEUROCHIRURGICA
Any: 2012
Referència: Acta Neurochir Suppl. 2012;114:39-44. doi: 10.1007/978-3-7091-0956-4_8.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Chambers, I; Citerio, G; Donald, Rob; Enblad, P; Gregson, B; Howells, Tim; Kiening, K; Mattern, J; Nilsson, P; Piper, Ian et al.
DOI: 10.1007/978-3-7091-0956-4_8

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.

PMID: 22538516
Revista: MODERN PATHOLOGY
Any: 2012
Referència: Mod Pathol. 2012 Jul;25(7):968-82. doi: 10.1038/modpathol.2012.52. Epub 2012 Apr 27.
Factor d'impacte: 4.792
Tipus de publicació: Article en revista internacional
Autors: Ortiz, Nazario, Franco, Renato, Ortiz-Hidalgo, Carlos, Suarez-Gauthier, Ana, Young, Ken H, Piris, Miguel A, Adrados, Magdalena, Ruiz-Marcellan, Carmen, Camacho, Francisca I, Mollejo, Manuela et al.
DOI: 10.1038/modpathol.2012.52

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.

PMID: 22538516
Revista: MODERN PATHOLOGY
Any: 2012
Referència: Mod Pathol. 2012 Jul;25(7):968-82. doi: 10.1038/modpathol.2012.52. Epub 2012 Apr 27.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Adrados, Magdalena; Camacho, Francisca I; Castillo, Maria E; de Villambrosia, Sonia Gonzalez; Diaz-Perez, Julio A; Franco, Renato; Garcia, Juan F; Lopez, Ana Batlle; Lopez, Mar; Mazorra, Francisco et al.
DOI: 10.1038/modpathol.2012.52

EBV-specific immune responses in patients with multiple sclerosis responding to IFN{beta} therapy.

PMID: 22020417
Revista: Multiple Sclerosis Journal
Any: 2012
Referència: Mult Scler. 2012 May;18(5):605-9. Epub 2011 Oct 21.
Factor d'impacte: 4.255
Tipus de publicació: Article en revista internacional
Autors: , , , , , et al.
DOI: 10.1177/1352458511426816

EBV-specific immune responses in patients with multiple sclerosis responding to IFN{beta} therapy.

PMID: 22020417
Revista: Multiple Sclerosis Journal
Any: 2012
Referència: Mult Scler. 2012 May;18(5):605-9. Epub 2011 Oct 21.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: ; ; ; ; ; et al.
DOI: 10.1177/1352458511426816

Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial.

PMID: 23588438
Revista: Nutricion Hospitalaria
Any: 2012
Referència: Nutr Hosp. 2012 Nov-Dec;27(6):1908-15. doi: 10.3305/nh.2012.27.6.5992.
Factor d'impacte: 1.12
Tipus de publicació: Article en revista internacional
Autors: Lozano, M A, Moreno, Y, Paron, L, de la Cuerda, C, Breton, I, Camblor, M, Garcia-Hernandez, J, Guarner, F, Hernandez, M, Velasco, C et al.
DOI: 10.3305/nh.2012.27.6.5992

Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial.

PMID: 23588438
Revista: Nutricion Hospitalaria
Any: 2012
Referència: Nutr Hosp. 2012 Nov-Dec;27(6):1908-15. doi: 10.3305/nh.2012.27.6.5992.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Breton, I; Camblor, M; de la Cuerda, C; Garcia-Hernandez, J; Garcia-Peris, P; Guarner, F; Hernandez, M; Lozano, M A; Moreno, Y; Paron, L et al.
DOI: 10.3305/nh.2012.27.6.5992

Effect of a plasma sodium biofeedback system applied to HFR on the intradialytic cardiovascular stability. Results from a randomized controlled study.

PMID: 22561583
Revista: NEPHROLOGY DIALYSIS TRANSPLANTATION
Any: 2012
Referència: Nephrol Dial Transplant. 2012 Oct;27(10):3935-42. doi: 10.1093/ndt/gfs091. Epub 2012 May 4.
Factor d'impacte: 3.396
Tipus de publicació: Article en revista internacional
Autors: , , , , , , , , , et al.
DOI: 10.1093/ndt/gfs091

Publicacions

Cercador de Publicacions

Drotrecogin Alfa (Activated) in Adults with Septic Shock.

Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.

Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.

Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer.

Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer.

Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen.

Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen.

E. coli O104:H4 outbreak and haemolytic-uraemic syndrome.

E. coli O104:H4 outbreak and haemolytic-uraemic syndrome.

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

Early Subclinical Rejection as a Risk Factor for Late Chronic Humoral Rejection.

Early Subclinical Rejection as a Risk Factor for Late Chronic Humoral Rejection.

Early treatment with eculizumab in atypical haemolytic uraemic syndrome.

Early treatment with eculizumab in atypical haemolytic uraemic syndrome.

Early warning of EUSIG-defined hypotensive events using a Bayesian Artificial Neural Network.

Early warning of EUSIG-defined hypotensive events using a Bayesian Artificial Neural Network.

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.

EBV-specific immune responses in patients with multiple sclerosis responding to IFN{beta} therapy.

EBV-specific immune responses in patients with multiple sclerosis responding to IFN{beta} therapy.

Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial.

Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial.

Effect of a plasma sodium biofeedback system applied to HFR on the intradialytic cardiovascular stability. Results from a randomized controlled study.

Patronat:

Col·labora:

Acreditacions: